Michael Rivner

Professor

Michael Rivner

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Neurology

Emeritus Faculty

The Graduate School

Medical College of Georgia
Department of Neuroscience and Regenerative Medicine

Administration
Department of The Graduate School

Bio

I am a specialist in Neuromuscular diseases. I established and run the ALS clinic. I have research grants in Myasthenia Gravis and ALS. I run the EMG lab at AUHealth. I also have an interest in botulinum toxins.

  • (706) 721-2681
  • (706) 721-8701
  • BP 4390

Education

  • MD, Medicine Emory University, 1978

  • BA, Psychology, General Duke University, 1972

  • BA, Zoology/Animal Biology Duke University, 1972

Certifications

  • PHY GA Composite Medical Brd, 1979

  • BLS 2014

Courses Taught Most Recent Academic Year

  • NEUR 5000

    Basic Clkshp in Neurology
  • RNEU 5000

    Neurology
  • NEUR 5020

    Neuromuscular Disease
  • NEUR 5022

    EMG Elective

Teaching Interests

EMG, ALS, Myasthenia Gravis, Neuromuscular diseases, botulinum toxin

Scholarship

Selected Recent Publications

  • Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial., 2025
    Journal Article, Academic Journal
  • Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial., 2024
    Journal Article, Academic Journal
  • Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study., 2024
    Journal Article, Academic Journal
  • Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis., 2023
    Journal Article, Academic Journal
  • Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis., 2021
    Journal Article, Academic Journal

Research Interests

EMG
ALS
Myasthenia Gravis
Botulinum Toxins

Professional Service

  • ALS Clinic 2007 - 2018

    Role: Director
  • EMG Lab 1983 - 2018

    Role: Director